Boehringer Ingelheim GmbH

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Digital Health
    • Disease Management

Other Names/Subsidiaries

  • Abexxa Biologics
  • Actimis Pharmaceuticals
  • Amal Therapeutics
  • Ben Venue Laboratories
  • Boehringer Ingelheim Seiyaku
  • ICD Therapeutics
  • NBE Therapeutics
  • Nerio Therapeutics
  • Nippon Boehringer Ingelheim
  • Northern Biologics
  • Pharmaton
  • Roxane Laboratories
  • SSP
  • Saiba Animal Health
  • T3 Pharmaceuticals
  • Vira Therapeutics
See more in Biomedtracker

Latest on Boehringer Ingelheim GmbH

Scrip

Deal Watch: Oak Hill Picks Up Where Roche Left Off In Angelman Syndrome

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Oak Hill Licenses Roche’s Rugonersen,

Scrip

Boehringer Boss Talks Tariffs And State Of Play In The US

 
• By Kevin Grogan

Hours before president Donald Trump unveiled sweeping US tariffs from which pharmaceuticals would appear to be exempt for now, Boehringer Ingelheim chairman Hubertus von Baumbach mused on the diffic

Scrip

Boehringer Still Sees Plenty Of Juice In Jardiance

 
• By Kevin Grogan

Boehringer Ingelheim’s ability to put billions of euros into its pipeline continues to be driven by Jardiance and chairman Hubertus von Baumbach believes that there is plenty more growth to come from

Scrip

Deal Watch: Eyenovia Looks At New Direction In Proposed Merger With Betaliq

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Eyenovia, Betaliq Will Have Combined C